January 2021 DAIDS Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year (FY) 2022 Concepts

FY 2022 Small Business Innovation Research (SBIR) Contract Solicitation Topics

Multidisciplinary Treatment Approaches To End the HIV Epidemic

For the published request for applications, see the March 30, 2021 Guide announcement, Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01, Clinical Trial Optional).

Prevention Strategies To End the HIV Epidemic

For the published request for applications, see the March 30, 2021 Guide announcement, Prevention Strategies to End the HIV Epidemic (R01, Clinical Trial Optional).

RESPOND: Epidemiology To End the HIV Epidemic

For the published request for applications, see the March 30, 2021 Guide announcement, Respond—Epidemiology to End the HIV Epidemic (RESPOND—EEE) (R01, Clinical Trial Optional).

Genetically Engineered Mice for Preclinical Evaluation of HIV Vaccine Candidates

Note: NIAID topic for NIH SBIR contract solicitation.

Request for Proposals

Contact: Charles H. Jackson, Jr.

Novel Platforms for Delivery and/or Expression of HIV Env Immunogens for HIV Vaccines

Note: NIAID topic for NIH SBIR contract solicitation.

Request for Proposals

Contact: Charles H. Jackson, Jr.

 

Content last reviewed on